CYT003, a TLR9 agonist, in persistent allergic asthma – a randomized placebo‐controlled Phase 2b study
暂无分享,去创建一个
T. Casale | C. Vogelmeier | P. Saudan | M. Wechsler | C. Lassen | J. Cole | E. Beck | J. Willers | A. Hammann-Haenni | L. Trokan | C. Vogelmeier | M. Wechsler | T. Casale